Acobiom Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $586K

  • Investors
  • 2

Acobiom General Information

Description

Developer of a biomedical technology designed to discover new transcriptomic biomarkers. The company's technology assists in developing and commercializing in-vitro diagnostics and companion diagnostics, notably for personalized medicine applications, and provides services in the fields of genomics, pharmacogenomics, and transcriptomics, for research purposes and clinical trials, enabling medical professionals to diagnose a disease or a pathogenic process, monitor patients during their treatment, and measure patient response to exposure or a therapy.

Contact Information

Website
www.acobiom.com
Formerly Known As
Skuldtech
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • 1682 Rue de la Valsière
  • Biopole Euromedecine II, Grabels, Cedex 04
  • 34790 Montpellier
  • France
+33 04
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Laboratory Services (Healthcare)
Corporate Office
  • 1682 Rue de la Valsière
  • Biopole Euromedecine II, Grabels, Cedex 04
  • 34790 Montpellier
  • France
+33 04

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acobiom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Angel (individual) 29-Dec-2023 $586K Completed Generating Revenue
6. Product Crowdfunding 15-Jan-2021 Completed Generating Revenue
5. Grant 30-Jan-2020 Completed Generating Revenue
4. Angel (individual) 09-Jul-2014 Completed Startup
3. Angel (individual) 03-May-2012 Completed Startup
2. Angel (individual) 07-Jun-2010 $164K $164K Completed Startup
1. Later Stage VC $5.66M Cancelled Startup
To view Acobiom’s complete valuation and funding history, request access »

Acobiom Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 2,030 $152.74 $152.74 1x $152.74 5.33%
Ordinary 1,774 $81.82 $81.82 1x $81.82 4.66%
To view Acobiom’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Acobiom Patents

Acobiom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025003612-A1 Method for determining the survival prognosis of a patient suffering from pancreatic cancer Inactive 27-Jun-2023
FR-3150527-A1 Method for determining the survival prognosis of a patient with pancreatic cancer Pending 27-Jun-2023
FR-3024946-B1 Method for determining the prognosis of survival of a patient with pancreas cancer Inactive 22-Aug-2014
FR-3024946-A1 Method for determining the prognosis of survival of a patient with pancreatic cancer Active 22-Aug-2014
FR-3025028-A1 Method for determining the prognosis of survival of a patient with pancreatic cancer Inactive 22-Aug-2014 C12Q1/6886
To view Acobiom’s complete patent history, request access »

Acobiom Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acobiom Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Health Accelerator/Incubator
Bpifrance Sovereign Wealth Fund Minority
To view Acobiom’s complete investors history, request access »

Acobiom FAQs

  • When was Acobiom founded?

    Acobiom was founded in 1999.

  • Where is Acobiom headquartered?

    Acobiom is headquartered in Montpellier, France.

  • What is the size of Acobiom?

    Acobiom has 7 total employees.

  • What industry is Acobiom in?

    Acobiom’s primary industry is Biotechnology.

  • Is Acobiom a private or public company?

    Acobiom is a Private company.

  • What is the current valuation of Acobiom?

    The current valuation of Acobiom is .

  • What is Acobiom’s current revenue?

    The current revenue for Acobiom is .

  • How much funding has Acobiom raised over time?

    Acobiom has raised $2.43M.

  • Who are Acobiom’s investors?

    EIT Health and Bpifrance have invested in Acobiom.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process